Colgate-Palmolive (India) Ltd
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]
- Market Cap ₹ 49,580 Cr.
- Current Price ₹ 1,823
- High / Low ₹ 2,330 / 1,716
- Stock P/E 36.2
- Book Value ₹ 58.2
- Dividend Yield 2.63 %
- ROCE 108 %
- ROE 82.7 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
- Company has been maintaining a healthy dividend payout of 112%
Cons
- Stock is trading at 31.4 times its book value
- The company has delivered a poor sales growth of 4.51% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 | 6,204 | |
| 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,165 | 4,304 | |
| Operating Profit | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 | 1,900 |
| OPM % | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 31% | 31% |
| 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 | 64 | 66 | |
| Interest | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 146 | 148 |
| Profit before tax | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 | 1,814 |
| Tax % | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | 26% | |
| 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 | 1,348 | |
| EPS in Rs | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 52.83 | 48.73 | 49.55 |
| Dividend Payout % | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% | 119% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 5% |
| 3 Years: | 8% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 2% |
| 3 Years: | -4% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 66% |
| 5 Years: | 75% |
| 3 Years: | 79% |
| Last Year: | 83% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,557 |
| 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 47 | |
| 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,777 | |
| Total Liabilities | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
| 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 718 | |
| CWIP | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 27 |
| Investments | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 |
| 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,663 | |
| Total Assets | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 638 | 689 | 688 | 694 | 983 | 930 | 784 | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 | |
| -272 | -237 | -342 | -207 | -96 | -19 | 71 | -108 | -8 | 79 | 56 | 374 | |
| -385 | -391 | -341 | -380 | -815 | -891 | -956 | -1,091 | -1,087 | -1,195 | -1,671 | -1,422 | |
| Net Cash Flow | -18 | 61 | 5 | 107 | 73 | 20 | -101 | 427 | 82 | 83 | -221 | 758 |
| Free Cash Flow | 339 | 417 | 367 | 485 | 879 | 869 | 727 | 1,576 | 1,107 | 1,123 | 1,323 | 1,730 |
| CFO/OP | 103% | 100% | 105% | 93% | 113% | 104% | 76% | 127% | 101% | 88% | 100% | 121% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 | 13 |
| Inventory Days | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 | 75 |
| Days Payable | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 | 275 |
| Cash Conversion Cycle | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 | -95 | -188 |
| Working Capital Days | -40 | -43 | -39 | -33 | -36 | -23 | -84 | -25 | -32 | -46 | -37 | -59 |
| ROCE % | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% | 108% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Dec 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSBF Children Reached (Cumulative since 1976) million children |
|
|||||||||||
| BSBF Children Reached (Annual) million children |
||||||||||||
| Direct Distribution Outlets (Smile Stores) million stores |
||||||||||||
| E-commerce Business Growth (Multiple vs Base Year) x (multiple) |
||||||||||||
| Toothbrush Volume Market Share % |
||||||||||||
| Toothpaste Volume Market Share % |
||||||||||||
| Top of Mind Brand Awareness (Colgate) % |
||||||||||||
| Premium Portfolio Growth (vs Category) x (multiple) |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Board Meeting Intimation To Approve And Take On Record The Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2026 And To Consider The Declaration Of Interim Dividend.
- Board meeting on October 22, 2026 to approve Q2/H1 FY2026-27 results and consider interim dividend.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Please find attached herewith Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Please find attached herewith Newspaper Publication.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Colgate India screened 3,08,106 students across 547 schools in Tamil Nadu and Puducherry, setting a world record.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Priyan Pillay resigns as EVP-Legal effective Oct. 23, 2026; Abhijit Yadav appointed from Oct. 24, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025PPT
-
Dec 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024PPT
-
Feb 2024PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Dec 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022PPT
-
May 2021Transcript PPT
-
Mar 2021PPT
-
Dec 2020PPT
-
Sep 2020PPT
-
May 2020Transcript PPT
-
May 2019PPT
-
Mar 2019PPT
-
May 2018Transcript PPT
-
May 2017PPT
Business Overview:[1][2]
Co. is the country's dominant oral care company operating across toothpaste, toothbrush, mouthwash, and personal care (Palmolive). Its 4 growth pillars are:
- Lead Toothpaste Category Growth,
- Transformative Accelerate Oral Care
- Premiumisation, Lead Category Growth
in Toothbrush, and
- Build Personal Care.